FDA Warns Indiana Oncologist Over Failure to Follow Trial Procedures

Clinical Trials Advisor
A A
Indianapolis oncologist Ruemu Birhiray was hit with an FDA warning letter after investigators uncovered multiple procedural failures at his clinical trial site.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00